EMA Recommends Bluevac-3 and Syvazul BTV 3 Vaccine...
Category : Approval/Launch 21 January 2025EMA has recommended the approval of the vaccines Bluevac-3 and Syvazul BTV 3 to protect sheep agains...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Fermion & Simcere Partner to Develop SSTR4 Pain Tr...
Category : Licensing/Collaboration Deal 21 January 2025Guangzhou Fermion Technology Co., Ltd., a clinical-stage, AI-driven biotech company, and Simcere Pha...
FDA Approves Zydus’ Phase IIb trial of Usnoflast f...
Category : Approval/Launch 21 January 2025The trial will test 50mg and 75mg doses of the therapy against a placebo. he US Food and Drug Admini...
Vivoryon Strengthens R&D Pipeline for Kidney Disea...
Category : Product Related Updates 16 January 2025Vivoryon Therapeutics N.V. (Vivoryon), a clinical stage company focused on the discovery and develop...
Teva Partners with Formycon to Commercialize FYB20...
Category : Licensing/Collaboration Deal 16 January 2025Klinge Biopharma GmbH (Klinge), the licensee and exclusive global commercialization rights holder fo...
Latest Newsletter Post
-
FDA Approves Zydus’ Phase IIb trial..
21 January 2025
-
Fermion & Simcere Partner to Develo..
21 January 2025
-
EMA Recommends Bluevac-3 and Syvazu..
21 January 2025
-
Teva Partners with Formycon to Comm..
16 January 2025
-
Vivoryon Strengthens R&D Pipeline f..
16 January 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com